Valuation: ABL Diagnostics

Market Cap 4.31Cr 4.92Cr 3.97Cr 3.68Cr 6.99Cr 469.05Cr 7.09Cr 47Cr 18Cr 230.24Cr 18Cr 18Cr 798.28Cr P/E 2024
123x
P/E 2025 50x
Enterprise Value 4.4Cr 5.02Cr 4.05Cr 3.76Cr 7.14Cr 479.21Cr 7.24Cr 49Cr 19Cr 235.23Cr 19Cr 18Cr 815.56Cr EV / Sales 2024
70,98,474x
EV / Sales 2025 61,85,843x
Free-Float
2.52%
Yield 2024
2.03%
Yield 2025 3.67%
1 day-3.73%
1 week-7.19%
Current month-7.19%
1 month-5.15%
3 months-12.84%
6 months-30.65%
Current year-14.00%
1 week 2.54
Extreme 2.54
2.96
1 month 2.2
Extreme 2.2
2.96
Current year 2.12
Extreme 2.12
5
1 year 2.12
Extreme 2.12
5.75
3 years 2.12
Extreme 2.12
9.7
5 years 1.99
Extreme 1.9875
26
10 years 1.28
Extreme 1.275
26
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
02/06
Advanced Biological Laboratories SA
SellCompany -57,692 0.3580%
27/05
Advanced Biological Laboratories SA
SellCompany -51,900 0.3221%
17/03
Advanced Biological Laboratories SA
SellCompany 54,745 0.3397%
Change 5-day change 1-year change 3-year change Capi.($)
-3.73%-7.19%-51.78%-71.17% 4.92Cr
+0.90%+6.28%-27.87%-9.32% 17TCr
+1.58%+8.01%-3.62%-1.62% 11TCr
+2.83%+8.51%+1.51%+60.89% 5.81TCr
+0.27%-0.62%+54.16%+57.62% 5.27TCr
+0.93%+4.06%-8.95%-38.71% 4.29TCr
+0.54%+9.13% - - 3.61TCr
-0.01%+7.66%-12.58%-42.77% 2.79TCr
-1.30%-1.64%+59.44%-4.97% 2.53TCr
+0.68%+1.94%-8.00%-1.46% 2.08TCr
Average +0.31%+3.26%+0.26%-5.72% 5.37TCr
Weighted average by Cap. +1.03%+2.76%-2.97%+3.67%

Financials

2024 2025
Net sales 5.87 6.7 5.41 5.02 9.53 639.27 9.66 64.71 25.18 313.79 25.17 24.62 1.09T 7.97 9.1 7.34 6.81 12.93 867.58 13.11 87.82 34.18 425.86 34.16 33.41 1.48T
Net income 3L 3L 3L 2L 5L 3.11Cr 5L 31.44L 12.24L 1.52Cr 12.23L 11.96L 5.29Cr 10L 11.27L 9L 8L 16.02L 11Cr 16.24L 1.09Cr 42.34L 5.28Cr 42.31L 41.38L 18Cr
Net Debt 20.24L 23.11L 18.64L 17.3L 32.86L 22Cr 33.3L 2.23Cr 86.84L 11Cr 86.78L 84.88L 38Cr 9L 10.65L 9L 8L 15.14L 10Cr 15.35L 1.03Cr 40.02L 4.99Cr 39.99L 39.11L 17Cr
Logo ABL Diagnostics
ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.
Employees
22
Date Price Change Volume
07/26/07 2.580 -3.73% 1,084
06/26/06 €2.680 +0.75% 1,145
03/26/03 €2.660 +0.76% 5,087
02/26/02 €2.640 -5.04% 67,260
01/26/01 €2.780 0.00% 7,954

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABLD Stock